Common Emotional Symptoms
- Persistent sadness or emptiness
- Hopelessness or helplessness
- Irritability or emotional withdrawal
- Loss of interest or pleasure
LOCATIONS: NEW YORK CITY | LONG ISLAND
BOOK YOUR CONSULTATION NOW: 917-261-7370
Explore personalized, evidence-based depression treatment options for patients in Melville and nearby Long Island communities. Eligible patients may receive insurance coverage for SPRAVATO® and other covered behavioral health services. IV ketamine infusions are not covered by insurance, but CareCredit financing may help patients manage treatment costs.
Depression can affect motivation, concentration, relationships, sleep, work performance, and overall quality of life. For patients who have not experienced enough improvement with traditional antidepressants, a specialized psychiatric evaluation may uncover additional evidence-based options.
NY Ketamine Infusions supports patients from Melville and surrounding Nassau and Suffolk County communities. Our team reviews prior treatment history, current symptoms, medical considerations, SPRAVATO® insurance requirements, IV ketamine self-pay options, and personal goals before recommending a course of care.
Major depressive disorder is a serious mental health condition that may involve changes in mood, thinking, energy, sleep, appetite, motivation, and day-to-day functioning. Symptoms vary from person to person and may become persistent even after counseling or medication trials.
Treatment recommendations are based on a comprehensive evaluation. Depending on clinical appropriateness, our providers may evaluate patients experiencing:
Insurance policies can differ significantly, even when two patients have coverage through the same carrier. Our team verifies potential SPRAVATO® benefits and explains plan requirements before treatment begins whenever possible. IV ketamine infusions are self-pay and are not covered by insurance, although CareCredit financing and possible out-of-network claim submission may be available.
We review your symptoms, diagnosis, treatment history, medications, medical history, and goals.
Our staff reviews potential SPRAVATO® benefits and identifies plan-specific authorization requirements.
For SPRAVATO®, supporting documentation may be submitted for insurer review. For IV ketamine, patients may explore CareCredit financing.
Your provider discusses clinically appropriate options, including insurance-covered SPRAVATO® when eligible or self-pay IV ketamine treatment.
The plans below may provide benefits for eligible SPRAVATO® patients. Coverage depends on the individual policy, diagnosis, medical necessity, prior authorization, network requirements, and current participation. These plans do not cover IV ketamine infusions.
SPRAVATO® is an FDA-approved prescription nasal spray containing esketamine. It may be considered for eligible adults with treatment-resistant depression and for certain adults with major depressive disorder accompanied by acute suicidal ideation or behavior, subject to current prescribing requirements and physician evaluation.
Many commercial insurance plans, as well as some Medicare and Medicaid plans, may provide coverage when plan criteria are met. Prior authorization is common and may require documentation of diagnosis, previous medication trials, treatment duration, response, and medical necessity. Review our SPRAVATO® insurance coverage information for additional details.
IV ketamine infusions for mental health treatment are not covered by insurance at NY Ketamine Infusions. The current self-pay fee is $525 per infusion. Discounts may be available for prepaid treatment packages and for eligible first responders, military members, teachers, and healthcare workers.
CareCredit financing may be available to qualifying patients, with monthly payment options that can make out-of-pocket treatment costs more manageable. Prequalification may be available without affecting the patient's credit score; approval and minimum monthly payments are subject to CareCredit terms.
Read the complete IV Ketamine Fees and Insurance information, or learn more about ketamine treatment for depression.
Treatment-resistant depression is generally used to describe major depressive disorder that has not improved adequately after multiple appropriate antidepressant trials. A careful psychiatric evaluation may help identify whether a different medication strategy, psychotherapy approach, insurance-covered SPRAVATO® treatment, self-pay IV ketamine treatment for depression, or another evidence-based option should be considered.
Your clinician considers medication names, doses, treatment duration, side effects, psychotherapy history, and the level of improvement achieved.
Sleep, anxiety, medical conditions, substance use, medication adherence, and diagnostic complexity may affect treatment response.
Recommendations are tailored to current symptoms, safety considerations, prior response, personal goals, and insurance requirements.
Our practice welcomes patients who live or work in Melville and nearby areas across western Suffolk County and eastern Nassau County. Travel distance varies by starting point and route.
Common regional routes include the Long Island Expressway (I-495), Northern State Parkway, Route 110/Broadhollow Road, Walt Whitman Road, and nearby local roads connecting Melville with surrounding communities.
Your first appointment is designed to create a complete picture of your symptoms, health history, previous treatment response, and current goals.
Many plans cover medically necessary behavioral health services, and eligible patients may receive coverage for SPRAVATO®. IV ketamine infusions are not covered by insurance at NY Ketamine Infusions and are offered on a self-pay basis.
Many plans may cover SPRAVATO® for eligible patients who meet FDA-approved prescribing criteria and plan-specific requirements. Prior authorization is commonly required. Visit our SPRAVATO® insurance coverage page for more information.
No. IV ketamine infusions for mental health treatment are not covered by insurance at NY Ketamine Infusions. Treatment is self-pay at the current rate listed on the Fees and Insurance page.
Treatment-resistant depression generally refers to major depressive disorder that has not responded adequately to multiple appropriate antidepressant trials. A psychiatric evaluation can help determine whether additional options should be considered.
Referral requirements vary by health plan. Some patients may schedule directly, while certain plans require a referral from a primary care physician or mental health provider.
Insurers may request a diagnosis, medication history, treatment duration, clinical response, medical records, physician documentation, and a statement of medical necessity.
Timing depends on the insurance company and whether additional review is necessary. Straightforward benefit checks may be completed faster than requests requiring prior authorization or supporting records.
Medicare may cover medically necessary behavioral health services. Coverage for a particular treatment depends on applicable Medicare rules, clinical eligibility, and the patient's plan.
New York Medicaid plans may cover eligible behavioral health services. Benefits, network requirements, and prior authorization rules vary by managed care plan and treatment.
Our team can explain anticipated costs before treatment begins. IV ketamine is self-pay, and qualifying patients may use CareCredit financing. SPRAVATO® coverage is verified separately based on medical necessity, authorization, and individual plan benefits.
Yes. CareCredit financing may be available for qualifying patients and may provide monthly payment options for out-of-pocket IV ketamine costs. Approval is subject to credit approval and CareCredit terms.
Yes. Patients who have not experienced adequate relief from antidepressants may request an evaluation to discuss their symptoms, previous treatments, and possible next steps.
Patients generally should not drive themselves home after these treatments. Specific transportation and next-day driving instructions should be reviewed with the clinical team before treatment.
NY Ketamine Infusions serves patients throughout Long Island, including Melville, Dix Hills, Huntington Station, Plainview, Farmingdale, Woodbury, Syosset, Commack, Deer Park, and nearby communities.
Request a consultation online or call the office. Our team can review scheduling, clinical intake, insurance information, and the next steps for an evaluation.
Patients in Melville and neighboring Long Island communities can request a confidential consultation to discuss insurance-covered SPRAVATO®, self-pay IV ketamine treatment, CareCredit financing, and other clinically appropriate depression care options.